Gang Liu1, Jian Shen1, Yuan Yang1, Xiang Li1, Yuansong Zhu1, Zhenxian Xiang1, Hongbo Gan1, Bi Huang2, Suxin Luo3. 1. Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, People's Republic of China. 2. Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, People's Republic of China. huangbi120@163.com. 3. Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, People's Republic of China. luosuxin0204@163.com.
Abstract
BACKGROUND: Previous studies have shown elevated admission heart rate (HR) was associated with worse outcome in patients with myocardial infarction (MI). However, the prognostic value of mean heart rate (MHR) with Holter monitoring remains unclear. OBJECTIVES: Our present study aims to evaluate the impact of MHR by Holter monitoring on long-term mortality in patients with ST-segment elevation myocardial infarction (STEMI). METHODS: 1013 STEMI patients were divided into four groups according to the quartiles of MHR by Holter monitoring, Q1 (< 66 bpm), Q2 66-72 bpm), Q3 (73-78 bpm), and Q4 (> 78 bpm). The endpoint was long-term all-cause mortality. The predictive value of admission HR, discharge HR, and MHR was compared with receiver operating characteristic (ROC) curves. RESULTS: Patients in Q4 were more likely to present with anterior MI, high Killip class, relatively lower admission blood pressure, significantly increased troponin I, B-type natriuretic peptide, and decreased left ventricular ejection fraction. During a median of 28.3 months follow up period, 91 patients (8.9%) died. The mortality in Q4 was significantly higher than in the other three groups (P < 0.001). After multivariate adjustment, Q4 was associated with a 1.0-fold increased risk of long-term all-cause mortality (HR = 2.096, 95% CI 1.190-3.691, P = 0.010). ROC analysis shows MHR with Holter (AUC = 0.672) was superior to admission HR (AUC = 0.556) or discharge HR (AUC = 0.578). CONCLUSIONS: MHR based on Holter monitoring provided important prognostic value and MHR > 78 bpm was independently associated with increased risk of long-term all-cause mortality in patients with STEMI, and its predictive validity was superior to admission or discharge HR.
BACKGROUND: Previous studies have shown elevated admission heart rate (HR) was associated with worse outcome in patients with myocardial infarction (MI). However, the prognostic value of mean heart rate (MHR) with Holter monitoring remains unclear. OBJECTIVES: Our present study aims to evaluate the impact of MHR by Holter monitoring on long-term mortality in patients with ST-segment elevation myocardial infarction (STEMI). METHODS: 1013 STEMI patients were divided into four groups according to the quartiles of MHR by Holter monitoring, Q1 (< 66 bpm), Q2 66-72 bpm), Q3 (73-78 bpm), and Q4 (> 78 bpm). The endpoint was long-term all-cause mortality. The predictive value of admission HR, discharge HR, and MHR was compared with receiver operating characteristic (ROC) curves. RESULTS: Patients in Q4 were more likely to present with anterior MI, high Killip class, relatively lower admission blood pressure, significantly increased troponin I, B-type natriuretic peptide, and decreased left ventricular ejection fraction. During a median of 28.3 months follow up period, 91 patients (8.9%) died. The mortality in Q4 was significantly higher than in the other three groups (P < 0.001). After multivariate adjustment, Q4 was associated with a 1.0-fold increased risk of long-term all-cause mortality (HR = 2.096, 95% CI 1.190-3.691, P = 0.010). ROC analysis shows MHR with Holter (AUC = 0.672) was superior to admission HR (AUC = 0.556) or discharge HR (AUC = 0.578). CONCLUSIONS: MHR based on Holter monitoring provided important prognostic value and MHR > 78 bpm was independently associated with increased risk of long-term all-cause mortality in patients with STEMI, and its predictive validity was superior to admission or discharge HR.
Authors: P Greenland; M L Daviglus; A R Dyer; K Liu; C F Huang; J J Goldberger; J Stamler Journal: Am J Epidemiol Date: 1999-05-01 Impact factor: 4.897
Authors: Magnus T Jensen; Jacob L Marott; Kristine H Allin; Børge G Nordestgaard; Gorm B Jensen Journal: Eur J Prev Cardiol Date: 2011-04-27 Impact factor: 7.804
Authors: Michael Böhm; Karl Swedberg; Michel Komajda; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi Journal: Lancet Date: 2010-09-11 Impact factor: 79.321
Authors: Magnus T Jensen; Marta Pereira; Carla Araujo; Anti Malmivaara; Jean Ferrieres; Irene R Degano; Inge Kirchberger; Dimitrios Farmakis; Pascal Garel; Marina Torre; Jaume Marrugat; Ana Azevedo Journal: Eur Heart J Acute Cardiovasc Care Date: 2016-09-30
Authors: Magnus Thorsten Jensen; Christoph Kaiser; Karl Erik Sandsten; Hannes Alber; Maria Wanitschek; Allan Iversen; Jan Skov Jensen; Sune Pedersen; Rikke Soerensen; Hans Rickli; Marzena Zurek; Gregor Fahrni; Osmund Bertel; Stefano De Servi; Paul Erne; Matthias Pfisterer; Søren Galatius Journal: Int J Cardiol Date: 2013-07-11 Impact factor: 4.164